Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy (Q80866690)
Jump to navigation
Jump to search
scientific article published on 01 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy |
scientific article published on 01 May 2008 |
Statements
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy (English)
David Palma
Scott Tyldesley
Tom Pickles
Prostate Cohort Outcomes Initiative